SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • July 6th, 2018 • Propanc Biopharma, Inc. • Pharmaceutical preparations • New York
This SECURITIES PURCHASE AGREEMENT (the “Agreement”), dated as of June 29, 2018, by and between PROPANC BIOPHARMA, INC, a Delaware corporation, with headquarters located at 302, 6 Butler Street, Camberwell, VIC 3124 Australia (the “Company”), and COVENTRY ENTERPRISES, LLC, with its address at 80 S.W. 8th Street, Suite 2000, Miami, FL 33130 (the “Buyer”).
